1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction
2024) In Journal of Cardiovascular Translational Research(
- Contribution to journal › Article
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
-
Mark
Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”
(
- Contribution to journal › Letter
- 2023
-
Mark
Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta
(
- Contribution to journal › Article
-
Mark
S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction
(
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
- 2021
-
Mark
Studying the innate immune response to myocardial infarction in a highly efficient experimental animal model
(
- Contribution to journal › Article
-
Mark
Targeting s100a9 reduces neutrophil recruitment, inflammation and lung damage in abdominal sepsis
(
- Contribution to journal › Article
-
Mark
Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation
(
- Contribution to journal › Article